[Transformation of lymphocytes during immunosuppressive therapy in lupus erythematosus visceralis].
D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001379:Azathioprine / Q000627:therapeutic use*; D046508:Culture Techniques; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D037102:Lectins / Q000494:pharmacology; D007958:Leukocyte Count; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D015122:Mercaptopurine / Q000627:therapeutic use*; D008875:Middle Aged; D013268:Stimulation, Chemical; D013301:Streptolysins / Q000494:pharmacology
D007166:Immunosuppressive Agents; D037102:Lectins; D013301:Streptolysins; D015122:Mercaptopurine; D001379:Azathioprine
Lymphozytentrasfromation unter immunsuppressiver Therapie beim Lupus erythematodes visceralis.